A carregar...
Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study
BACKGROUND: Glatiramer acetate (GA) and interferon-beta (IFN-β) are disease-modifying therapies (DMTs) for multiple sclerosis that are administered through subcutaneous (SC) or intramuscular (IM) injections. Skin reactions associated with DMTs are common and may influence patient’s health-related qu...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3854544/ https://ncbi.nlm.nih.gov/pubmed/24131589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-13-146 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|